Clinical Trials

Lymphoma, Large B-Cell, Diffuse

NCT01336933 2023-09-22

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Phase 2 Completed

34 enrolled 12 charts

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT01075321 2020-10-22

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Phase 1/2 Completed

58 enrolled 12 charts

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT00898963 2020-07-31

Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

175 enrolled

Lymphoma, Lymphoma, Follicular

NCT01284010 2020-02-20

Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia

200 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00899366 2020-02-05

DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia

49 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00691652 2019-11-27

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Phase 1/2 Terminated

2 enrolled 4 charts

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01150643 2017-05-17

Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab

559 enrolled

Lymphoma, Lymphoma, Follicular

NCT00896922 2017-02-28

S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911

180 enrolled

Lymphoma, Lymphoma, Follicular

NCT01366170 2016-05-19

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

7 enrolled

Lymphoma, Lymphoma, Large-Cell, Anaplastic

NCT01366157 2016-05-17

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

23 enrolled

Hodgkin Disease, Lymphoma

NCT00899899 2015-09-30

Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission

135 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00900406 2012-11-06

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

190 enrolled

Testicular Germ Cell Tumor, Breast Neoplasms, Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Gestational Trophoblastic Disease, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT00055640 2010-06-10

Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma

Phase 2 Completed

9 enrolled